The manufacturer of Narcan, the overdose reversal medication that received over-the-counter status last month, says it aims to price a two-pack of the medication at less than $50.
In a statement Thursday, Emergent BioSolutions said it will take “a responsible approach to pricing” as Narcan becomes available over the counter. While many addiction and overdose experts celebrated its new over-the-counter status, they have also warned that it will do little good unless Narcan is sold at an affordable price.
Before Narcan received over-the-counter approval, Emergent offered discount pricing for public interest groups, like nonprofits and local health agencies. On average, those groups paid less than $50 for a two-pack, the company said.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
